Jitschin et al. have shown that M-MDSCs from chronic lymphocytic leukemia (CLL) patients suppress T-cell activation and promote Treg induction, which is partly dependent on IDO activity (95). This evidence concerns the gene IDO1 and B-cell chronic lymphocytic leukemia.